Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002854947 | SCV003622911 | uncertain significance | Inborn genetic diseases | 2022-06-03 | criteria provided, single submitter | clinical testing | The c.1847G>A (p.G616E) alteration is located in exon 34 (coding exon 34) of the COL13A1 gene. This alteration results from a G to A substitution at nucleotide position 1847, causing the glycine (G) at amino acid position 616 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003143550 | SCV003833406 | uncertain significance | Congenital myasthenic syndrome 19 | 2021-03-11 | criteria provided, single submitter | clinical testing |